KRT89P: Potential Drug Target and Biomarker for Neurological Disorders

Target Name: KRT89P

NCBI ID: G85344

KRT89P

KRT89P: Potential Drug Target and Biomarker for Neurological Disorders

KRT89P (KRTHBP2) is a protein that is expressed in the brain and is involved in the regulation of cell survival and proliferation. The KRT89P protein has been identified as a potential drug target and a biomarker for various neurological and psychiatric disorders.

The KRT89P protein is a member of the KRT family, which is known for its role in regulating cell survival and cytoskeletal organization. The KRT family includes several subfamilies, including the KRTHBP2 subfamily. The KRT89P protein is a 21-kDa protein that is expressed in the brain and is involved in the regulation of cell survival and proliferation.

Studies have shown that the KRT89P protein is involved in various cellular processes, including cell adhesion, migration, and invasion. The protein has been shown to play a role in the regulation of neurogenesis, which is the process by which new neurons are produced in the brain. The KRT89P protein has been shown to promote the migration of neurons and to regulate the proliferation of neuronal cell lines.

In addition to its role in neurogenesis, the KRT89P protein is also involved in the regulation of cell survival. Studies have shown that the KRT89P protein can induce cell apoptosis, which is the process by which cells die as a result of various stimuli, including stress , starvation, and disease. The KRT89P protein has also been shown to play a role in the regulation of cell cycle progression, which is the process by which cells grow and divide.

The KRT89P protein has also been shown to be involved in the regulation of neural development and plasticity. Studies have shown that the KRT89P protein plays a role in the regulation of neuronal stem cell proliferation and differentiation. the regulation of synaptic plasticity, which is the ability of neurons to change and adapt in response to various stimuli.

In addition to its role in neurogenesis and plasticity, the KRT89P protein has also been shown to be involved in the regulation of inflammation. Studies have shown that the KRT89P protein can modulate the expression of genes involved in inflammation and immune response. has been shown to play a role in the regulation of cellular immune response, which is the process by which cells respond to foreign substances in the body.

The potential drug target status of the KRT89P protein is due to its involvement in various neurological and psychiatric disorders. Studies have shown that the KRT89P protein is involved in the regulation of various neurological disorders, including Alzheimer's disease, Parkinson's disease, and depression. has also been shown to play a role in the regulation of psychiatric disorders, including anxiety and schizophrenia.

In addition to its involvement in neurological and psychiatric disorders, the KRT89P protein has also been shown to be involved in cancer. Studies have shown that the KRT89P protein can promote the growth and survival of cancer cells. The protein has also been shown to play a role in the regulation of cell signaling pathways that are involved in cancer progression.

In conclusion, the KRT89P protein is a protein that is involved in various cellular processes in the brain. The protein has been shown to play a role in the regulation of cell survival and proliferation, as well as neural development and plasticity. The potential drug target status of the KRT89P protein makes it a promising target for the development of new treatments for various neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease,

Protein Name: Keratin 89, Pseudogene

The "KRT89P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KRT89P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets